|Podcasts|December 9, 2021
Episode 97: Diving Into Our 2022 Pipeline Report
Author(s)Elaine Quilici, Miranda Schmalfuhs
Mike Ward, Global Head of Thought Leadership in the Decision Resources Group at Clarivate, goes behind the numbers of our 2022 pipeline report and provides some interesting insights from the report provided by his company.
Advertisement
Mike Ward, Global Head of Thought Leadership in the Decision Resources Group at Clarivate, discusses our 2022 pipeline report, appearing in our December issue. Mike goes behind the numbers and provides some interesting insights from the report provided by Clarivate.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
FDA’s New Pilot Program and Real-Time Review of Clinical Data
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5